Cargando…
Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
OBJECTIVE: The GOLD guidelines suggest that the presence of a post-bronchodilator forced expiratory volume in one second (FEV(1)) < 80% of the predicted value in combination with a FEV(1)/forced vital capacity (FVC) < 70% confirms the diagnosis of COPD. Limited data exist regarding the accurac...
Autores principales: | Richter, Daphne C, Joubert, James R, Nell, Haylene, Schuurmans, Mace M, Irusen, Elvis M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650596/ https://www.ncbi.nlm.nih.gov/pubmed/19281083 |
Ejemplares similares
-
Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018) -
Smoking status and second-hand smoke biomarkers in COPD, asthma and healthy controls
por: Bradicich, Matteo, et al.
Publicado: (2020) -
Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007) -
COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014) -
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
por: Kang, Jieun, et al.
Publicado: (2017)